Follow The Filings

GRI GRI Bio

GRI Bio earnings company data as of 4:48 AM ET 10/23

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS -1.20 -0.91 Beat
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A
8-K 7.01,8.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 8.01,9.01
8-K 2.02,8.01,9.01
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
424B5
8-K 1.01,9.01
10-K
8-K 8.01,9.01
8-K 3.03,5.03,8.01,9.01
8-K 3.01
8-K 5.07,8.01
424B5
8-K 8.01,9.01
8-K 8.01,9.01
DEF 14A
SCHEDULE 13G —
SCHEDULE 13G —
8-K 1.01,9.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Sep 18, 2025 (5 forms)

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.